H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
21%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Meta-Analysis of Ubiquilin1 Gene Polymorphism and Alzheimer’s Disease Risk

Tianpeng Zhang, Yingying Jia

(Department of Integrated TCM & Western Medicine, People’s Hospital, Hegang City, Heilongjiang, China (mainland))

Med Sci Monit 2014; 20:2250-2255

DOI: 10.12659/MSM.891030

Published: 2014-11-12


Background: Some studies have evaluated the association between the Ubiquilin 1 (UBQLN1) gene UBQ-8i polymorphism and Alzheimer’s disease (AD). However, the results remain uncertain. We carried out a meta-analysis to derive a more comprehensive estimation of this association.
Material and Methods: Case-control studies were identified by searching databases of PubMed, EMBASE, Web of Science, CNKI, CBM, Wanfang, and VIP. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association.
Results: The UBQ-8i polymorphism was significantly associated with an increased AD risk (OR=1.15; 95%CI 1.05–1.25; P=0.002). The combination of adjusted ORs also found UBQ-8i polymorphism was significantly associated with AD risk (OR=1.15; 95%CI 1.02–1.30; P=0.02). When stratified by APOE ε4 status, both APOE ε4 carriers and APOE non-ε4 carriers with UBQ-8i polymorphism had significantly increased AD risk (OR=1.28; 95%CI 1.05–1.56; P=0.01 and OR=1.25; 95%CI 1.04–1.50; P=0.02). In the subgroup analysis according to age, UBQ-8i polymorphism was significantly associated with LOAD risk (OR=1.17; 95%CI 1.05–1.31; P=0.005), but not with EOAD risk (OR=1.12; 95%CI 0.95–1.31; P=0.17).
Conclusions: These results suggest that the UBQ-8i polymorphism is associated with AD risk.

Keywords: Aged, 80 and over, Aged, Alzheimer Disease - genetics, Carrier Proteins - genetics, Case-Control Studies, Cell Cycle Proteins - genetics, Genetic Predisposition to Disease, Humans, Middle Aged, Polymorphism, Genetic, Risk Factors



Back